• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC Back to Search Results
Catalog Number PFRT01
Device Problem Material Erosion (1214)
Patient Problems Bleeding (1738); Erosion (1750); Pain (1994); Scar Tissue (2060); Other (for use when an appropriate patient code cannot be identified) (2200); Surgical procedure (2357)
Event Type  Injury  
Event Description
It was reported by an attorney that the patient underwent a gynecological procedure on (b)(6) 2005 and mesh was implanted.It was reported that she experienced pain, erosion of her internal bodily tissue and other injuries following the procedure.It was reported that the patient has undergone multiple surgeries and revisionary procedures.No additional information was provided.
 
Manufacturer Narrative
(b)(4).Should additional information be obtained, a supplemental 3500a form will be submitted accordingly.(b)(4).Total number of events - 306.Gynecare prolift +m anterior pelvic floor repair system - 13.Gynecare prolift +m pelvic floor repair system - 7.Gynecare prolift +m posterior pelvic floor repair system - 20.Gynecare prolift +m total pelvic floor repair system - 22.Gynecare prolift anterior pelvic floor repair system - 69.Gynecare prolift pelvic floor repair system - 47.Gynecare prolift posterior pelvic floor repair system - 35.Gynecare prolift total pelvic floor repair system - 63.Gynecare prosima pelvic floor repair system - 30.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
During the initial procedure, the patient underwent an anterior and posterior repair, vaginal vault suspension.Following the insertion, the patient experienced pain, erosion, urinary problems, bleeding and vaginal scarring.(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).Reporting period (b)(6) 2014.Supplemental report 14.
 
Manufacturer Narrative
(b)(4).Reporting period april 1, 2014 through may 31, 2014.
 
Manufacturer Narrative
Date sent to the fda: 02/22/2017.(b)(4).Reporting period april 1, 2014 through may 31, 2014.Supplemental report 16.
 
Manufacturer Narrative
Date sent to the fda: 04/19/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2014.Supplemental report 18.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2014 through (b)(6) 2014 supplemental report 23 - attachment: [(b)(6) 2014 otp supplemental 23.Xlsx].
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
 
Manufacturer Narrative
Date sent to fda: 12/26/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2014 through may 31, 2014.
 
Manufacturer Narrative
Date sent to fda: 02/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2014 through may 31, 2014.
 
Manufacturer Narrative
Date sent to fda: 04/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2014 through may 31, 2014.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON SARL-NEUCHATEL
puits-godet 20 2000 neuchatel
neuchatel
SZ  
Manufacturer Contact
guillermo villa
route 22 west po box 151
somerville, NJ 08876
9082180707
MDR Report Key3897964
MDR Text Key4544623
Report Number2210968-2014-03873
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K013718
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,other
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 03/26/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2006
Device Catalogue NumberPFRT01
Device Lot Number1298938
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/24/2014
Initial Date FDA Received06/26/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
03/24/2014
03/24/2014
03/24/2014
03/24/2014
03/24/2014
03/24/2014
03/24/2014
10/26/2018
12/26/2018
02/12/2019
04/24/2019
Supplement Dates FDA Received08/29/2014
10/29/2014
12/30/2014
02/23/2015
04/28/2015
06/22/2015
10/26/2015
12/21/2015
02/23/2016
04/20/2016
06/20/2016
08/22/2016
10/25/2016
12/19/2016
02/22/2017
04/19/2017
06/26/2017
08/28/2017
10/23/2017
12/20/2017
02/27/2018
04/18/2018
06/21/2018
08/16/2018
10/28/2018
12/26/2018
02/12/2019
04/24/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/07/2005
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-